Canada says working with FDA to address EpiPen shortage
TORONTO (Reuters) - Canada's government health agency said on Tuesday it is working with the U.S. Food and Drug Administration to address a shortage of Mylan N.V.'s EpiPen emergency allergy antidote that has hit several countries outside of the United States, where it is manufactured.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Allergy | Allergy & Immunology | Canada Health | Emergency Medicine | Food and Drug Administration (FDA) | Government | Health | USA Health